Extranodal marginal zone B ‐cell lymphoma of mucosa‐associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients

ConclusionsThis study suggests that the outcome after initial treatment of MALT lymphomas in the oromaxillofacial head and neck region is satisfactory and that this disease progresses slowly. The CR rate and PFS of localized lymphoma patients are better than those of disseminated lymphoma patients. Systemic treatment (chemotherapy or rituximab) may improve PFS in disseminated disease patients. MALT ‐IPI and Ann Arbor staging are independent prognostic factors.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: ORIGINAL RESEARCH Source Type: research